NASDAQ: VTYX

Ventyx Biosciences Inc Stock Forecast, Predictions & Price Target

The consensus among 6 Wall Street analysts covering (NASDAQ: VTYX) stock is to Buy VTYX stock.

Out of 6 analysts, 2 (33.33%) are recommending VTYX as a Strong Buy, 1 (16.67%) are recommending VTYX as a Buy, 3 (50%) are recommending VTYX as a Hold, 0 (0%) are recommending VTYX as a Sell, and 0 (0%) are recommending VTYX as a Strong Sell.

If you're new to stock investing, here's how to buy Ventyx Biosciences stock.

(NASDAQ: VTYX) Ventyx Biosciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.23%.

Ventyx Biosciences's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast VTYX's revenue for 2026 to be $19,760,065,868, with the lowest VTYX revenue forecast at $19,760,065,868, and the highest VTYX revenue forecast at $19,760,065,868. On average, 2 Wall Street analysts forecast VTYX's revenue for 2027 to be $20,917,856,767, with the lowest VTYX revenue forecast at $1,937,551,812, and the highest VTYX revenue forecast at $39,898,161,723.

In 2028, VTYX is forecast to generate $42,101,164,058 in revenue, with the lowest revenue forecast at $6,132,618,122 and the highest revenue forecast at $78,069,709,995.

According to 6 Wall Street analysts that have issued a 1 year VTYX price target, the average VTYX price target is $9.33, with the highest VTYX stock price forecast at $16.00 and the lowest VTYX stock price forecast at $2.00.

On average, Wall Street analysts predict that Ventyx Biosciences's share price could reach $9.33 by Mar 13, 2025. The average Ventyx Biosciences stock price prediction forecasts a potential upside of 114.55% from the current VTYX share price of $4.35.

(NASDAQ: VTYX) forecast ROE is N/A, which is considered weak.